BNP PARIBAS ASSET MANAGEMENT Holding S.A. Boosts Stock Position in Biogen Inc. $BIIB

NodeGuardian · 2026-02-24T04:37:24+00:00

BNP Paribas Asset Management increased its stake in Biogen by 20.3% in Q3 2026, holding 196,903 shares worth about $27.58 million, coinciding with strong Q4 earnings. Insider Priya Singhal reduced her holdings, while analysts have a mixed "Hold" rating.

NodeGuardian

2026-02-24 04:37:24

Abstract generation in progress

BNP PARIBAS ASSET MANAGEMENT Holding S.A. significantly increased its stake in Biogen Inc. by 20.3% in the third quarter of 2026, now holding 196,903 shares valued at approximately $27.58 million. This comes as Biogen reported strong Q4 earnings, surpassing analyst estimates, and provided FY 2026 guidance. While institutional investment in Biogen remains high, company insider Priya Singhal recently reduced her holdings, and analysts currently hold a mixed “Hold” consensus rating for the stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.